Gianluca Pirozzi
Direktor/Vorstandsmitglied bei TREX WIND-DOWN, INC.
Vermögen: 1 $ am 31.03.2024
Aktive Positionen von Gianluca Pirozzi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TREX WIND-DOWN, INC. | Direktor/Vorstandsmitglied | 01.05.2020 | - |
Independent Dir/Board Member | 01.05.2020 | - | |
ALEXION PHARMACEUTICALS, INC. | General Counsel | 01.10.2019 | - |
Karriereverlauf von Gianluca Pirozzi
Ehemalige bekannte Positionen von Gianluca Pirozzi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.09.2018 | 01.05.2020 |
Sanofi SA | Corporate Officer/Principal | 01.04.2014 | 01.09.2019 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Ausbildung von Gianluca Pirozzi
Sapienza University of Rome | Doctorate Degree |
Università Campus Bio-Medico di Roma | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Italien | 3 |
Frankreich | 2 |
Operativ
Director/Board Member | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TREX WIND-DOWN, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Health Technology |
Sanofi SA | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Gianluca Pirozzi
- Erfahrung